Insys Sells Flagship Opioid Subsys In Bankruptcy Proceeding
WILMINGTON, Del. — A Delaware federal bankruptcy judge on Sept. 19 approved the sale of the opioid drug Subsys to BTcP Pharma LLC (In Re: Insys Therapeutics, Inc., et al., No....To view the full article, register now.
Already a subscriber? Click here to view full article